The RATPAC (randomised assessment of treatment using panel assay of cardiac markers) trial: A randomized controlled trial of point-of-care cardiac markers in the emergency department

Health Technology Assessment

Volumn 15, Issue 23, 2011, Pages 1-108

  Goodacre, S ^a   Bradburn, M ^a   Fitzgerald, P ^a   Cross, E ^a   Collinson, P ^b   Gray, A ^c   Hall, A S ^d  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b ST GEORGE S HOSPITAL   (United Kingdom)

^c ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^d UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTACID AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOLOGICAL MARKER; CLOPIDOGREL; CREATINE KINASE MB; FIBRINOGEN RECEPTOR ANTAGONIST; GLYCERYL TRINITRATE; HEPARIN; MYOGLOBIN; TROPONIN I;

ABSENTEEISM; ACUTE HEART INFARCTION; ADULT; AGE; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD ANALYSIS; COMORBIDITY; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; COST EFFECTIVENESS ANALYSIS; DEVICE RECALL; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST ACCURACY STUDY; ECONOMIC EVALUATION; ELECTROCARDIOGRAPHY; EMERGENCY SURGERY; EMERGENCY WARD; FALSE POSITIVE RESULT; FEMALE; FOLLOW UP; HEALTH CARE COST; HEALTH CARE QUALITY; HEALTH CARE UTILIZATION; HEART ARRHYTHMIA; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; INTERMETHOD COMPARISON; ISCHEMIC HEART DISEASE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MEDICAL DECISION MAKING; MORTALITY; MULTICENTER STUDY; ONLINE SYSTEM; OPEN STUDY; OUTCOME ASSESSMENT; PATIENT SATISFACTION; PATIENT TRANSPORT; PERCUTANEOUS CORONARY INTERVENTION; POINT OF CARE TESTING; PROBABILITY; PROSPECTIVE PAYMENT; QUALITY ADJUSTED LIFE YEAR; RANDOMIZED CONTROLLED TRIAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SEX RATIO; UNITED KINGDOM;

ADULT; AGED; BIOLOGICAL MARKERS; COST-BENEFIT ANALYSIS; CREATINE KINASE, MB FORM; EMERGENCY SERVICE, HOSPITAL; FEMALE; HEALTH STATUS; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOGLOBIN; PATIENT SATISFACTION; POINT-OF-CARE SYSTEMS; QUALITY-ADJUSTED LIFE YEARS; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TROPONIN;

EID: 79960747981     PISSN: 13665278     EISSN: None     Source Type: Journal    
DOI: 10.3310/hta15230     Document Type: Article

References (54)

1. Goodacre S, Cross E, Arnold J, Angelini K, Capewell S, Nicholl J. The health care burden of acute chest pain. Heart 2005;91:229-30.
2. Department of Health (DoH). The National Service Framework for Coronary Heart Disease. London: DoH; 2000.
3. Thygesen K, Alpert JS, White HD; Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction. J Am Coll Cardiol 2007;50:2173-95.
4. Ebell MH, White LL, Weismantel D. A systematic review of troponin T and I values as a prognostic tool for patients with chest pain. J Fam Pract 2000;49:746-53.
5. Bertrand ME, Simoons ML, Fox KAA, Wallentin LC, Hamm CW, McFadden E, et al. Task Force on the Management of Acute Coronary Syndromes of the European Society for Cardiology. Management of acute coronary syndromes in patients presenting without ST elevation. Eur Heart J 2002;23:1809-40.
6. Goodacre S, Calvert N. Cost effectiveness of diagnostic strategies for patients with acute, undifferentiated chest pain. Emerg Med J 2003;20:429-33.
7. Reichlin T, Hochholzer W, Bassetti S, Steuer S, Stelzig C, Hartwiger S, et al. Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N Engl J Med 2009;361:858-67.
8. Keller T, Zeller T, Peetz D, Tziwas S, Roth A, Czyz E, et al. Sensitive troponin I assay in early diagnosis of acute myocardial infarction. N Engl J Med 2009;361:868-72.
9. Collinson PO, Premachandram S, Hashemi K. Prospective audit of incidence of prognostically important myocardial damage in patients discharged from the emergency department. BMJ 2000;320:1702-5.
10. Goodacre S, Nicholl J, Dixon S, Cross E, Angelini K, Arnold J, et al. Randomised controlled trial and economic evaluation of a chest pain observation unit compared with routine care. BMJ 2004;328:254-7.
11. Goodacre S, Nicholl J, Beahan J, Quinney D, Capewell S. National survey of emergency department management of patients with acute, undifferentiated chest pain. Br J Cardiol 2003;10:50-4.
12. Collinson PO, John C, Lynch S, Rao A, Canepa-Anson R, Carson E, et al. A prospective randomised controlled trial of point-of-care testing on the coronary care unit. Ann Clin Biochem 2004;41:397-404.
13. Renaud B, Maison P, Ngako A, Cunin P, Santin A, Hervé J, et al. Impact of point-of-care testing in the emergency department evaluation and treatment of patients with suspected acute coronary syndromes. Acad Emerg Med 2008;15:216-24.
14. Ryan RJ, Lindsell CJ, Hollander JE, O'Neil B, Jackson R, Schreiber D, et al. A multicenter randomized controlled trial comparing central laboratory and point-of-care cardiac marker testing strategies: the Disposition Impacted by Serial Point of Care Markers in Acute Coronary Syndromes (DISPO-ACS) trial. Ann Emerg Med 2009;53:321-8.
15. Kendall J, Reeves B, Clancy M. Point of care testing: randomised controlled trial of clinical outcomes. BMJ 1998;316:1052-7.
16. Ebell MH, Flewelling D, Flynn CA. A systematic review of troponin T and I for diagnosing acute myocardial infarction. J Fam Pract 2000;49:550-6.
17. Balk EM, Ioannidis JPA, Salem D, Chew PW, Lau J. Accuracy of cardiac biomarkers to diagnose acute cardiac ischaemia in the emergency department: a meta-analysis. Ann Emerg Med 2001;37:478-94.
18. Fesmire FM, Percy RF, Bardoner JB, Wharton DR, Calhoun FB. Serial creatinine kinase (CK) MB testing during the emergency department evaluation of chest pain: utility of a 2-hour deltaCK-MB of +1.6 ng/ml. Am Heart J 1998;136:237-44.
19. Fesmire FM, Christensen RH, Focy EP, Feintuch TA. Delta creatinine kinase MB outperforms myoglobin at two hours during the emergency department identification and exclusion of troponin positive non-ST elevation acute coronary syndromes. Ann Emerg Med 2004;44:12-19.
20. McCord J, Nowak RM, McCullough PA, Foreback C, Borzak S, Tokarski G, et al. Ninetyminute exclusion of acute myocardial infarction by use of quantitative point-of-care testing of myoglobin and troponin I. Circulation 2001;104:1483-8.
21. Apple FS, Christensen RH, Valdes R, Andriak Aj, Berg A, Duh SH, et al. Simultaneous rapid measurement of whole blood myoglobin, creatinine kinase MB and cardiac troponin I by the triage cardiac panel for detection of myocardial infarction. Clin Chem 1999;45:199-205.
22. Newby LK, Storrow AB, Gibler WB, Garvey JL, Tucker JF, Kaplan AL, et al. Bedside multimarker testing for risk stratification in chest pain units: the CHECKMATE study. Circulation 2001;103:1832-7.
23. Caragher TE, Fernandez BB, Jacobs FL, Barr LA. Evaluation of quantitative cardiac biomarker point of care testing in the emergency department. J Emerg Med 2002;22:1-7.
24. Ng SM, Krishnaswamy P, Morissey R, Clopton P, Fitzgerald R, Maisel AS, et al. Ninetyminute accelerated critical pathway for chest pain evaluation. Am J Cardiol 2001;88:611-17.
25. Hamilton AJ, Swales LA, Neill J, Murphy JC, Darragh KM, Rocke LG, et al. Risk stratification of chest pain patients in the emergency department by a nurse utilizing a point of care protocol. Eur J Emerg Med 2008;15:9-15.
26. Rathore S, Knowles P, Mann APS, Dodds PA. Is it safe to discharge patients from accident and emergency using a rapid point of care triple cardiac marker test to rule out acute coronary syndrome in low to intermediate risk patients presenting with chest pain? Eur J Int Med 2008;19:537-40.
27. Straface AL, Myers JH, Kirchick HJ, Blick KE. A rapid point-of-care cardiac marker testing strategy facilitates the rapid diagnosis and management of chest pain patients in the emergency department. Am J Clin Pathol 2008;129:788-95.
28. Eggers KM, Oldgren J, Nordenskjold A, Lindahl B. Diagnostic value of serial measurement of cardiac markers in patients with chest pain: limited value of adding myoglobin to troponin I for exclusion of myocardial infarction. Am Heart J 2004;148:574-81.
29. Antman EM, Cohen M, Berninck PJ, Horacek T, Papuchis G, Mautner B, et al. The TIMI risk score for unstable angina/non-ST elevation MI: a method for prognostication and therapeutic decision making. JAMA 2000;284:835-42.
30. Eagle KA, Lim MJ, Dabbous OH, Pieper KS, Goldberg RJ, Van de Werf F, et al. A validated prediction model for all forms of acute coronary syndrome. JAMA 2004;291:2727-33.
31. Burtonwood C, Halloran S. Report 06020: three point of care devices for troponin measurement. London: NHS Purchasing and Supply Agency, Centre for Evidence-based Purchasing; 2006.
32. Panteghini M, Pagani F, Yeo KT, Apple FS, Christenson RH, Dati F, et al. Evaluation of imprecision for cardiac troponin assays at low-range concentrations. Clin Chem 2004;50:327-32.
33. Heeschen C, Goldmann BU, Moeller RH, Hamm CW. Analytical performance and clinical application of a new rapid bedside assay for the detection of serum cardiac troponin I. Clin Chem 1998;44:1925-30.
34. Heeschen C, Goldmann BU, Langenbrink L, Matschuck G, Hamm CW. Evaluation of a rapid whole blood ELISA for quantification of troponin I in patients with acute chest pain. Clin Chem 1999;45:1789-96.
35. Altinier S, Mion M, Cappelletti A, Zaninotto M, Plebani M. Rapid measurement of cardiac markers on Stratus CS. Clin Chem 2000;46:991-3.
36. Goodacre S, Cross E, Lewis C, Nicholl J, Capewell S, On behalf of the ESCAPE Research Team. The ESCAPE cluster randomised trial: effectiveness and safety of chest pain assessment to prevent emergency admissions. BMJ 2007;335:659-62.
37. Goodacre S, Mason S, Arnold J, Angelini K. Psychological morbidity and health-related quality of life of patients assessed on a chest pain observation unit. Ann Emerg Med 2001;38:369-76.
38. Conway Morris A, Caesar D, Gray S, Gray A. The TIMI risk score accurately risk stratifies patients with undifferentiated chest pain presenting to an emergency department. Heart 2006;92:1333-4.
39. Keating L, Benger J, Beetham R, Bateman S, Veysey S, Kendall J, Pullinger R. The PRIMA study: presentation IMA in the emergency department. Emerg Med J 2006;23:764-8.
40. Ramsey S, Willke R, Briggs A, Brown R, Buxton M, Chawla A, et al. Good research practices for cost-effectiveness analysis alongside clinical trials: The ISPOR RCT-CEA Task Force Report. Value Health 2001;8:521-33.
41. National Institute for Clinical Excellence (NICE). Guide to the methods of technology appraisal. London: NICE; 2004.
42. Netten A, Curtis L. Unit costs of health and social care 2004. Canterbury: University of Kent, Personal Social Services Research Unit; 2004.
43. Department of Health (DoH). NHS reference costs 2005. URL: www.dh.gov.uk/PolicyAndGuidance/OrganisationPolicy/FinanceAndPlanning/NHSReferenceCosts/fs/en
44. Fenwick E, Claxton K, Sculpher M. Representing uncertainty: the role of cost effectiveness acceptability curves. Health Econ Lett 2001;10:779-87.
45. Schafer J. Analysis of incomplete multivariate data. London: Chapman & Hall/CRC; 2000.
46. Rubin D. Multiple imputation for nonresponse in surveys. New York, NY: J Wiley & Sons; 1987.
47. Briggs A. Probabilistic analysis of cost-effectiveness models: statistical representation of parameter uncertainty. Value Health 2005;8:1-2.
48. Oluboyede Y, Goodacre S, Wailoo AJ on behalf of the ESCAPE Research Team. Costeffectiveness of chest pain unit care in the NHS. BMC Health Serv Res 2008;8:174.
49. Medical Research Council. Guidelines for Good Clinical Practice in Clinical Trials. 1998. URL: www.mrc.ac.uk/Utilities/Documentrecord/index.htm?d=MRC002416
50. British Medical Association and Royal Pharmaceutical Society of Great Britain. British national formulary. No. 58, March 2008. London: BMA and RPS; 2008.
51. Goodacre S, Morris F, Arnold J, Angelini K. Is a chest pain observation unit likely to be cost saving in a British hospital? Emerg Med J 2001;18:11-14.
52. Curtis L. PSSRU unit costs of health and social care. Canterbury: PSSU; 2008.
53. Goodacre S, Dixon S. Is a chest pain observation unit likely to be cost effective at my hospital? Extrapolation of data from a randomised controlled trial. Emerg Med J 2005;22:418-22.
54. Department of Health. NHS reference costs 2007-8.URL: www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/documents/digitalasset/dh_098949.xls